Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Steady as she goes: M&A experts weigh in on what is changing (and what isn’t)

December 20, 2016 By Heather Thompson

Medtech M&A OEM appetites

[Image courtesy of Basheer Tome on Flickr, per Creative Commons 2.0 license]

M&A experts have some good news for medtech startups: Large companies’ appetites for acquiring new companies and technologies remains reliable as ever.

Device Talks, which was held in Newport Beach, Calif., last week, featured a panel of M&A experts including advisors from Greenberg Traurig, Caldera Medical Group, Cerus and Locust Walk. The group discussed overall M&A in medtech trends, as well as technologies that are trending now, and how startups are navigating the space.

One of the most reassuring observations was that, in general, medtech M&A is stable. Kleanthis Xanthopoulus, managing general partner at Cerus DMCC, presented data from BMO Capital Markets.

“We have decades of data [showing] that M&A is not a trend, rather it is a steady part of the ecosystem,” Xanthopolous said, noting that such news is welcome to the medtech market.

“This is healthy and good,” he said. “Companies get acquired and then re-fertilize to create new ideas.”

Such steadfastness is not always visible, and Xanthopolous says he doesn’t mean to imply that the medtech industry is not subject to peaks and valleys.

“We saw spikes in IPOs during 2014 and 2015, likewise we saw spikes in follow-ons during 2015 and 2016,” he explained.

Other panelists noted that some trends are not always favorable to start-ups, which has prompted them to adjust and change how they carry out M&A. For example, Stewart Davis, senior vice president of Locust Walk, said that acquisitions are happening much later in the startup cycle.

“We are seeing deals happen later, sometimes after a startup is showing revenue.”

Although this is good for acquirers, Davis said it makes it more difficult and risky for start-ups.

“The acquirer can base the decision on real numbers rather than projections, which usually means more risk and lower reward for the acquired company,” he said.

In order to reduce that risk, startups are adopting techniques to make themselves more valuable, said Eric Geismer, EVP and general counsel for Caldera Medical Group.

“Small companies are using a roll-up strategy to create value and be more alluring for acquisition,” he said.

The group also noted that approaches to therapeutic areas also support the notion that value is part of the product in multiple ways. Ginger Pigott, shareholder for Greenberg Traurig and vice-chair of its pharmaceutical, medical device & healthcare litigation practice, observed that small and mid-sized companies are focusing on the healthcare ecosystem. Rick Tache, also a shareholder at Greenberg Traurig and co-chair of its global patent litigation group, echoed that idea, saying there’s a convergence of software and cloud computing embedded into medical technology. Such technology adds value to medical device products in how they will be used in a healthcare setting and is also a product differentiator strategy.

Convergence is a therapeutic trend as well, according to Xanthopoulus, noting the increasing number of drug-device combos. Davis said he’s excited to see more robotic-assisted surgical products in the future.

Overall, the panelists agreed that medtech is showing healthy M&A activity and that the companies being acquired can demonstrate clear value to the healthcare system and to potential buyers.

Want to stay on top of MDO content? Subscribe to our weekly e-newsletter.

Related Articles Read More >

cybersecurity
Moody’s warns of cybersecurity, antitrust and supplier risks for medical device companies
Integer Holdings
Integer buys Aran Biomedical for $131.1 million
BD Diabetes Spinoff Embecta
How Embecta is ‘uniquely positioned’ in diabetes space following spinoff from BD
The CartiHeal Agili-C implant for treating cartilage lesions
Bioventus plans to buy CartiHeal for at least $315M to launch knee implant

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech